We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients (CADIRIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00988780
Recruitment Status : Unknown
Verified November 2012 by Juan G. Sierra Madero, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.
Recruitment status was:  Active, not recruiting
First Posted : October 2, 2009
Last Update Posted : November 27, 2012
Information provided by (Responsible Party):